CARES Act Provider Relief Fund Update

| April 27, 2020

CARES Act Provider Relief Fund Update

NOTE: Be aware of a scam sent to physicians related to PPP_CARES_SignaturePG1-2. It requests you open and sign a file – DO NOT open and/or download any files.

The Department of Health and Human Services (HHS) released important information about the Provider Relief Fund. The Advocacy Council highly recommends you read HHS’ frequently asked questions on the program. If, after reading this document, you have more questions, please send them to the Advocacy Council and we will try to get them answered in a future update to the FAQ document.


HHS is authorized to distribute $175 billion from the CARES Provider Relief Fund to providers and suppliers enrolled in Medicare or Medicaid programs. Recipients include hospitals, private practice physicians, medical groups, nurse practitioners, physician assistants and other clinicians and facilities. HHS has announced that Provider Relief funds will be disbursed via both “general” and “targeted” distributions.

Thus far, HHS has authorized the release of $50 billion as a "general" distribution: 

  • $ 26 billion on 4/10
  • $ 4 billion on 4/17
  • $ 20 billion on 4/24

As of April 24, approximately $40 billion of the $50 billion authorized for general distribution has been deposited in providers’ accounts. Also, $10 billion of the general distribution remains to be distributed based on information recipients must submit on the Provider Relief Fund application. 

Attestation for funds already received (4/10, 4/17 and 4/24)

All allergists that have received a Provider Relief payment must submit an attestation form accepting the terms and conditions for receipt of these funds. HHS has set up an electronic portal to submit the forms. Failure to submit the attestation form will be deemed acceptance of the terms and conditions. You may want to review the terms and conditions prior to entering the portal.

Application Portal for additional general disbursements

As previously noted, approximately $10 billion of the general distribution funds remain unobligated. The Provider Relief Fund application portal will collect information from providers who received general distribution payments prior to April 24 at 5:00 pm EST and who wish to be considered for an additional disbursement from the general distribution allocation

If you are eligible (i.e., enrolled in Medicare or Medicaid in 2019) but did not receive any funds from the April 10, 17 or 24 releases, it is likely you are ineligible for any of the remaining $10 billion general distribution. However, we believe many allergists will be eligible for a future targeted distribution

When you enter the application portal, HHS will ask you to provide:

  1. The provider's gross receipts or sales or program service revenue as submitted on his federal income tax return.
  2. The provider's estimated revenue losses in March and April 2020 due to COVID-19.
  3. A copy of the provider's most recently filed federal income tax return.
  4. A listing of the Tax Identification Numbers of any of the provider's subsidiary organizations that have received relief funds but do not file separate tax returns.


Provider Relief Funds set aside, but not released

HHS has announced that they are setting aside some of the Provider Relief Fund money for certain targeted groups that have been hard hit by the COVID-19 virus or who HHS has determined are particularly vulnerable due to COVID-related lost revenue: 

  • High impact COVID-19 hospitals – $10 billion
  • Rural health clinics/rural hospitals – $10 billion
  • Indian health service facilities – $400 million
  • COVID-related care to uninsured – amount unspecified


Targeted distributions 

If you did not receive any money from the Provider Relief Fund this does not mean you are ineligible for the targeted distributions.  Some allergists who have not received any Provider Relief payments thus far will likely be eligible to obtain a Provider Relief Fund payment through a "targeted" distribution. The Advocacy Council will continue to advocate for a share of future targeted distributions be available to allergists. As information on HHS’ plans for these future targeted distributions becomes available, we will share with our members.

The Advocacy Council – we have you covered!